We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Anti Iba1, Rabbit Monoclonal Antibody (6A4), recombinant Data
Performance Data
Comparison with our conventional product (rabbit polyclonal antibody)
Polyclonal Antibody
(Product No. 019-19741)


Monoclonal Antibody
(Product No. 018-28523)


Species: Rat
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:200
Data by courtesy of
Dr. Nakajima, Faculty of Science and Engineering, Soka University
Comparison with company A (rabbit monoclonal antibody)
Company A
(rabbit, monoclonal)


Fujifilm Wako
(Product No. 018-28523)


Species: Mouse
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:1,000
Application Data
Immunohistochemistry
Mouse


Species: Mouse
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:1,000


Species: Mouse
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:200
Data by courtesy of
Dr. Koizumi, Interdisciplinary Graduate School of Medicine, University of Yamanashi


Species: Mouse
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:200
Note: Preparation of frozen sections → PFA fixation
Data by courtesy of
Dr. Ino, Graduate School of Medicine, Osaka University


Species: Mouse
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:1,000
Data by courtesy of
Dr. Nonaka, Graduate School of Engineering, Kyoto University


Species: Mouse
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:1,000
Data by courtesy of
Dr. Ito, Graduate School of Medicine, Juntendo University


Species: Mouse
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:1,000
Data by courtesy of
Dr. Tsuruta and Mr. Ueda, Faculty of Life and Environmental Sciences, University of Tsukuba


Species: Mouse
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:1,000
Data by courtesy of
Dr. O, S University


Species: Mouse
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:1,000
Data by courtesy of
Dr. Y, Institute of R


Species: Mouse (APPNL-F/NL-F)
Site: Cerebrum
Sample: Fixed tissue slice
Antibody concentration: 1:200
Note: Tissue clearing with Scale method
Data by courtesy of
Dr. Hama, RIKEN Center for Brain Science


Species: Mouse (Model of Alzheimer Disease)
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:500
Data by courtesy of
Dr. Konishi, Graduate School of Medicine, Nagoya University


Species: Mouse (Model of Focal Stroke)
Site: Cerebral cortex
Sample: Paraffin section
Antibody concentration: 1:500
Data by courtesy of
Dr. M, C University


Species: Mouse (Model of neuronal ceroid lipofuscinoses)
Site: Cerebral cortex
Sample: Paraffin section
Antibody concentration: 1:500
Data by courtesy of
Dr. T and S, J University


Species: Mouse
Site: Hippocampus
Sample: Frozen section
Antibody concentration: 1:1,000
Data by courtesy of
Dr. F, A University


Species: Mouse (APPNL-G-F)
Site: Hippocampus
Sample: Frozen section
Antibody concentration: 1:1,000
Data by courtesy of
Dr. Takatori, Graduate School of Pharmaceutical Sciences, University of Tokyo


Species: Mouse
Site: Brainstem (Principal sensory trigeminal nucleus)
Sample: Vibratome section
Antibody concentration: 1:500
Note: Tissue clearing with Scale method
Data by courtesy of
Dr. Ueta, School of Medicine,
Tokyo Women's Medical University


Species: Mouse
Site: Retina (Post-surgery)
Sample: Frozen section
Antibody concentration: 1:500
Data by courtesy of
Dr. Hayashi, School of Medicine, Aichi Medical University


Species: Mouse
Site: Retina (Flat-mount)
Sample: Frozen section
Antibody concentration: 1:2,000
Data by courtesy of
Dr. Watanabe, Dr. Iwagawa, University of Tokyo Hospital


Species: Mouse
Site: Retina (Flat-mount)
Antibody concentration: 1:1,000
Data by courtesy of
Dr. Watanabe, Dr. Iwagawa, University of Tokyo Hospital
Normal


Activated


Species: Mouse
Site: Retina (Cross-section)
Sample: Frozen section
Antibody concentration: 1:2,000
Data by courtesy of
Dr. Watanabe, Dr. Iwagawa, University of Tokyo Hospital


Species: Mouse
Site: Spinal cord
Sample: Frozen section
Antibody concentration: 1:2,000
Data by courtesy of
Dr. Hagiwara and Mr. Sawada, Faculty of Science and Technology, Tokyo University of Science


Species: Mouse
Site: Lumbar spinal cord
Sample: Frozen section
Antibody concentration: 1:1,200
Data by courtesy of
Dr. Takase, Graduate School of Medical Sciences, Kyushu University


Species: Mouse
Site: Lung
Sample: Paraffin section
Antibody concentration: 1:1,000
Data by courtesy of
Dr. K, N University
Rat


Species: Rat
Site: Cerebral cortex
Sample: Frozen section
Antibody concentration: 1:1,000


Species: Rat
Site: Cerebral cortex (Medial prefrontal cortex)
Sample: Frozen section
Antibody concentration: 1:1,000
Data by courtesy of
Dr. Ohta, Faculty of Medicine, Kagawa University
Immunocytochemistry


Cell line: SIM-A9
Antibody concentration: 1:200
Data by courtesy of
Dr. I, University of T
The data shown above are courtesy of the researchers and do not guarantee experimental results.
Please note that Fujifilm Wako cannot answer any questions regarding the data above.
Flow Cytometry
The microglial cell line BV-2 cells were fixed and permeabilized using the BD Cytofix/Cytoperm™ Fixation/Permeabilization Kit (BD Biosciences, 554714). Cells were then stained with either buffer, isotype control, or this product, followed by staining with the PE-labeled secondary antibody (SouthernBiotech, 4030-09). The fluorescence-labeled cells were analyzed by flow cytometry.


Result: Fixed and permeabilized BV-2 cells were successfully detected using the anti Iba1 antibody and flow cytometry.
User Voice
Researchers evaluated this antibody during the "Anti-Iba1 Rabbit Monoclonal Antibody Free Sample Campaign" held from March to May 2023 in Japan. Below are the results of the survey submitted by the researchers.
Results of the survey (N=33)
Q. Please tell us how satisfied you are with this antibody.






Q. Would you like to use this product in the future?


Q. How did this product compare to the anti-Iba1 antibody you are currently using?

